Exclusive negotiations: Lumibird sells its medical division

The Lumibird Group announces that it has entered into exclusive negotiations with IPG Photonics Corporation for the sale of its medical division. The proposed transaction values this division at €300 million, with a potential additional €50 million, depending on future performance.

This sale marks a crucial step in Lumibird's history, allowing it to focus its efforts on the photonics sector. Integration with IPG Photonics should offer the medical division growth prospects and international development opportunities through a well-established partner.

For its part, Lumibird plans to capitalize on the expanding photonics markets, particularly defense, space and industry, by strengthening its role as a European leader in this field.